CCM/Market Reports-/Production, Market and Benchmarking of Biotin in China

¡¡

(home)
CCM
consultancy
Market reports
Trade Analysis
newsletters & Information
conferences & events
coming report
ValoTracer
about us
careers 
contact
Always Primary Findings
Online Payment
samples
 

click here for sample pages

 

CCM>Market Reports>

 

No. 0004B001 Production, Market and Benchmarking of Biotin in China  - Edition(3)

 

 

About This Report:

 

Report edition:  2008 edition(3)
Language version: English
Document type: PDF File,(*.pdf)
For ready report --    
  Finished in: Sep 2008 ,edition(3)
  Total pages: 86
  Delivery: Delivery within 1-1 work days by email
  Price/copy: - USD10000.00 for single user
    -USD25000.00 for corporate license/site license
For update report --  
  Delivery time: Delivery within 20-40 work days upon confirmation
  Price/copy: - USD12000.00 for single user PDF
    - USD30000.00 for corporate license/site license

 

* The corporate license/site license is only for the sole and confidential use within the subscriber company and its affiliates in which the subscriber company owns, directly or indirectly, a fifty percent or greater, financial interest.

 

Report Edition List:

 

Version Finished in Availability Language   Pages   Delivery Price/Copy (For single user)
update report - update on request English - within 20-40 work days upon confirmation USD12000.00
2008,edition(3) Sep,2008 available English 86 within 1-1 work days by email USD10000.00
2005,edition(2) Jun,2005 available English 73 within 1-1 work days by email USD5000.00

 

 

Description:

 

Compared with other types of vitamins, biotin is a small product by volume. The total output of biotin in the world is estimated to be 100 tonnes per year.

As the largest biotin production country, China has accounted for nearly 80.0% of the global biotin supply. Meanwhile, after years of development, China’s biotin production technology in China has been the most advanced in the world.

This report looks into the development history, production, import/export, consumption, technology innovation and the benchmarking of biotin in China. Meanwhile, this report also researches the supply situation and price trend of raw materials involved in biotin production. Based on in-depth investigation, CCM forecasts the production and demand of biotin in China to 2013.

With this report, you can not only find the main players, the raw material supply situation and their price trend, but also the current biotin production technology situation of China’s producers, and their production cost in China,.

Biotin trade and consumption are also covered in this report. In these parts, you can find out the main export destinations of Chinese biotin, and the biotin consumption pattern in China, as well as the main end users.

What’s more, all the four biotin producers in China are profiled with in-depth analysis.

 

Main Content:

 

No. Content
Page
Executive Summary
5
Introduction and methodology
9
I Production and market information of Biotin in China
12
I-1 Development history of Biotin production in China
12
I-2 Current production situation of Biotin in China
14
I-2.1 Summary of manufacturers
14
I-2.2 Summary of production
15
I-2.3 Pricing trend
18
I-3 Brief introduction to raw materials involved in Biotin production
19
- Supply situation
- Price and its trend in the future
I-4 Trade of Biotin in 2007
25
I-4.1 Import situation
25
I-4.2 Export situation
26
I-5 Consumption pattern of Biotin in China
29
I-5.1 Overview of the Biotin Consumption in China
30
I-5.1.2 Historical situation of consumption from 2003 to 2007
30
I-5.2 Biotin consumption in feed industry
32
I-5.3 Biotin consumption in fermentation industry
34
I-5.4 Biotin consumption in healthcare products and pharmaceutical industry
35
I-6 Future forecast
36
I-6.1 Key factors and driven forces for the development of Biotin in China
36
I-6.1.1 Drivers
36
I-6.1.2 Barrier
38
I-6.2 Future Forecast on Biotin in the Next 5 Years
38
II Benchmarking of Biotin
42
II-1 Introduction to this work
42
II-2 Theoretical Analysis
42
II-2.1 Technology Research
42
II-2.2 Extraction method
43
II-2.3 Ferment method
43
II-2.4 Chemical synthesis Method
44
II-2.4.1 Process A
46
II-2.4.2 Process B
51
II-3 Players' Analysis
56
II-3.1 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
56
II-3.2 Zhejiang Shengda Pharmaceutical CO., Ltd.
63
II-3.3 Zhejiang NHU Co., Ltd.
66
II-3.4 Comparison of manufacturers
69
II-4 Tel interview and site visit with Dr. Fen'er Chen
70
III Situation of Chinese Manufacturers
73
III-1. Introduction to Active Manufacturers
73
III-1.1 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
73
III-1.2 Shanghai Desano Vitamins Co., Ltd.
77
III-1.3 Zhejiang NHU Co., Ltd.
80
III-1.4 Zhejiang Shengda Pharmaceutical Co., Ltd.
82
IV Conclusion
86

LIST OF TABLES
TableI-1.1 Active manufacturers of biotin in China, 2005
Table I-2.1-1 The biotin manufacturers having stopped production before 2005
Table I-2.1-2 The active manufacturers of biotin in China, 2008
Table I-2.3-1 The quotations of biotin from different manufacturers in China, Sep. 2008 (unit: RMB/kg)
Table I-3-1 The active manufacturers of tri-phosgene in China in Sep.2008
Table I-3-2 The active manufacturers of cyclic acid in China, 2008
Table I-3-3 The quotation of tri-phosgene in China, Sep. 2008
Table I-3-4 The quotation of cyclic acid in China, Sep.2008
TABLE I-4.1-1 The import situation of biotin in China, 2007(Quantity (kg); Price (USD/kg); Value (USD))
Table I-4.2-1 Export price of biotin in 2007 (Quantity (kg); Price (USD/kg); Value (USD))
Table I-4.2-1 Exporters of biotin in 2007 (Quantity (kg); Price (USD/kg); Value (USD))
Table I-4.2-3 Export situation of Chinese manufacturers in 2007 (Quantity (kg); Price (USD/kg); Value (USD))
Table I-4.2-4 Export destination of biotin in 2007 (Quantity (kg); Price (USD/kg); Value (USD))
Table I-5.1.2-1 Biotin consumption pattern in China from 2003-2007
Table I-5.2-1 Recommended adding dosage of biotin in different feeds and total biotin demands
Table I-5.2-2 Biotin consumption in feed in 2007
Table I-5.2-3 List of some biotin end users in feed industry in China, 2008
Table I-5.3-1 List of some biotin end users in fermentation industry in China, 2008
Table I-5.4-1 The dosage of biotin in healthcare products
Table I-5.4-2 List of some biotin end users in healthcare products and pharmaceutical industry in China, 2008
Table II-2.3-1 Energy consumption of Biotin production in ferment method
Table II-2.4.1-1 Yield rate of each reaction of Process A
Table II-2.4.1-2 Estimation on raw material consumption for Process A
Table II-2.4.2-1 Yield rate of each reaction of Process B
Table II-2.4.2-2 Estimation on raw material consumption for Process B
Table II-3.1.2 -1
Table II-3.1.2-2 Estimation on manufacturing cost of Biotin in Zhejiang Xinchang in September 2008
Table II-3.1.2-3 Estimation on the total production cost of Biotin in Zhejiang Xinchang in September 2008
Table II-3.1.2-4 Estimation on the profit of Biotin in Zhejiang Xinchang in September 2008
Table II-3.2.2 -1
Table II-3.2.2-3 Estimation on the total production cost of Biotin in Zhejiang Shengda in September 2008
Table II-3.2.2-4 Estimation on the profit of Biotin in Zhejiang Shengda in September 2008
Table II-3.3.2 -1
Table II-3.3.2-2 Estimation on manufacturing cost of Biotin in Zhejiang NHU in September 2008
Table II-3.3.2-3 Estimation on the total production cost of Biotin in Zhejiang NHU in September 2008
Table II-3.3.2-4 Estimation on the profit of Biotin in Zhejiang NHU in September 2008
Table II-3.4-1 Comparison of the three Biotin manufacturers
Table III-1.1-1 Output of biotin in Zhejiang Xinchang in past years
Table III-1.1-2 Price of biotin in Zhejiang Xinchang in the past years
Table III-1.1-3 Raw material consumption of Biotin in Zhejiang Xinchang in September 2008
Table III-1.1-4 Biotin export situation of Zhejiang Xinchang in 2007
Table III-1.2-1 Output of biotin in Shanghai Desano in the past years
Table III-1.2-2 Prices of biotin in Shanghai Desano in 2005 and 2008
Table III-1.2-3 Biotin export situation of Shanghai Desano in 2007
Table III-1.3-1 Output of biotin in Zhejiang NHU, 2002~2007
Table III-1.3-2 Price of biotin in Zhejiang NHU in past years
Table III-1.3-3 Raw material consumption of biotin in Zhejiang NHU as of September 2008
Table III-1.3-4 Biotin export situation of Zhejiang NHU in 2007
Table III-1.4-1 Output of biotin in Zhejiang Shengda, 2003~2007
Table III-1.4-2 Price of biotin in Zhejiang Shengda in past years
Table III-1.4-3 Raw material consumption of biotin in Zhejiang Shengda as of September 2008
Table III-1.4-4 Biotin export situation of Zhejiang NHU in 2007

LIST OF FIGURES
Figure I-2.2-1 The capacity of major biotin manufacturers in China, 2003~2008
Figure I-2.2-2 The capacity share of main biotin manufacturers in China, 2008
Figure I-2.2-3 The estimated output of biotin in China, 2003~2007
Figure I-2.2-4 The output share of different biotin manufacturers in China, 2007
Figure I-2.3-1 The historical price of 2% biotin in China
Figure I-3-1 Output and demand of fumaric acid in China, 2003~2007
Figure I-3-2 The consumption pattern of fumaric acid in China, 2007
Figure I-3-3 The estimated consumption pattern of phosgene in China, 2007
Figure I-3-4 The share of cyclic acid producers in China, by capacity, 2008
Figure I-3-5 The average price fumaric acid in China, Jun. 2004~Mar.2008
Figure I-5.1.1-1 Production and consumption of biotin in China, by volume, 2005-2007
Figure I-5.1.2-2 Biotin consumption structure in China in 2007
Figure I-6.1.1-1 Production of compound feed in China from 2000-2007
Figure I-6.1.1-2 China’s production and export situation of biotin from 2003-2007
Figure I-6.2-1 China’s GDP growth from 2003-2007
Figure I-6.2-2 Future demand for biotin in China, 2008-2013
Figure I-6.2-3 Future output of biotin in China, 2008-2013
Figure II-2.4.1-1 Flow chart of Process A
Figure II-2.4.2-1 Flow chart of Process B
Figure II-3.1.1-1 Flow chart of synthesis process of Biotin in Zhejiang Xinchang

Part of Report: click here for sample pages

Executive Summary

(Note: The following summary is based on the situation in 2008 and maybe different to what it is nowadays. Please be noted.)



Since XXX Company realized commercial production of biotin in June 2001, China has been the largest production country and main biotin exporter in the world. After years of development, the current production technology of biotin in Chinese producers has been the most advanced in the world.

- Production
As of Sep 2008, there are only xx active manufacturers of biotin in China, with the total capacity of xxxxt/a in 2008, much larger than the xxxxt/a in 2003. With the expanding capacity, China’s output of biotin has been increasing in the period 2003~2007 and the total output has been increasing with CAGR of xx% in the past five years, reaching xxxx tonnes in 2007.

As to the raw materials involved in biotin production, both their supply and price will be stable in the coming years.

- Import & export
China has been an important biotin export country in the world. In 2007, China exported xxxxkg biotin bulk pharmaceutical and xxxxkg feed grade biotin (2%). The main destinations are United States, Germany, Netherlands and India and so on. The export value of biotin to these four destinations accounted for xx% of China’s total biotin export in 2007.
- Forecast
According to CCM’s research, the following are the key drivers for the development of biotin in China:
- The development of feed industry
- The constant demand from the overseas market
- Government support
- New application in healthcare products
- Centralized production and mature technology

Macro factors influencing biotin’s demand and production are considered in this chapter including economic situation. Forecast is made based on these macro factors and other factors. Meanwhile, in making forecast, three scenarios are used. They are low growth, expected growth and high growth Based on the three scenarios mentioned above, CCM makes the forecast on the production and demand of biotin in China to 2013.

- Benchmarking
In China, only chemical synthesis method is adopted to produce biotin, and it includes two chemical synthesis methods. One is inefficient and used by XXX Company; the other one is advanced and used by XXX Company and XXX Company.

All the Chinese manufacturers produce biotin with the raw material beginning from cyclic acid.

......

......

(The rest content of this report is omitted.)

Character of CCM' Report:

This multi-client report provides a comprehensive study on the researched subject in China, from aspects of production, technology, import & export, consumption & end uses, etc.

>>
 All the producers in China, either active or idled or potential, have been sourced and contacted. Their situation has been verified and compiled as in the appendix.
>>
 The competitiveness of Chinese production has been discussed in order to uncover the mystery of ever-increasing capability of Chinese manufacturing.
>>
 The import & export analysis for the situation in the recent three years has been conducted.
>>
 The consumption pattern of the researched subject has been carried out in order to breakdown the end uses into different segments. The major end users under each major end use segments have been identified.
>>
 The scientific methodology has been employed to conduct the quantitative forecast on this subject in the future 5-10 years.

The aim of this report is to provide powerful assistance to the strategy group and the management team in making correct decision as how to penetrate the ever-increasing China market and how to catch the maximum commercial opportunities. The report is formulated independently by CCM’s professional market researchers, based on the first-hand and primary data which are analyzed by scientific methodology, confirmed with both manufacturers/end users/traders and legal authorities, and presented in a logic way.

Remark:

If you are not satisfied with the above main content, or if you would like to add additional requirements to the mentioned subject, or if you could not find your interested item(s) via the search engine, you are advised to go to Single-Client Services and Advisor, or Contact Us.